Shanghai Allist Pharmaceuticals Co., Ltd. Stock
Equities
688578
CNE100005XJ7
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.50 CNY | +2.16% |
|
+4.21% | -7.35% |
| Capitalization | 43.42B 6.39B 5.42B 4.97B 4.68B 8.73B 609B 8.8B 58.9B 22.99B 290B 23.98B 23.47B 1,003B | P/E ratio 2026 * |
16.4x | P/E ratio 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise value | 43.42B 6.39B 5.42B 4.97B 4.68B 8.73B 609B 8.8B 58.9B 22.99B 290B 23.98B 23.47B 1,003B | EV / Sales 2026 * |
6.36x | EV / Sales 2027 * | 5.53x |
| Free-Float |
45.98% | Yield 2026 * |
0.48% | Yield 2027 * | 0.55% |
| 1 day | +2.16% | ||
| 1 week | +4.21% | ||
| Current month | +4.21% | ||
| 1 month | -0.21% | ||
| 3 months | +0.65% | ||
| 6 months | -5.22% | ||
| Current year | -7.35% |
| 1 week | 92.62 |  | 97.18 |
| 1 month | 90.92 | | 101.33 |
| Current year | 87.4 | | 110.56 |
| 1 year | 80.53 | | 122.2 |
| 3 years | 22.16 | | 122.2 |
| 5 years | 14.81 | | 122.2 |
| 10 years | 14.81 | | 122.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Hao Du
CEO | Chief Executive Officer | 72 | 2022-09-13 |
Lin Wang
DFI | Director of Finance/CFO | 43 | 2023-04-09 |
Li Jun Wang
ADM | Chief Administrative Officer | 45 | 2005-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Yan
BRD | Director/Board Member | 44 | 2019-11-27 |
Jin Hao Du
CHM | Chairman | 72 | 2004-03-21 |
Rong Gang Xie
BRD | Director/Board Member | 40 | 2019-11-27 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.16% | +4.21% | +13.54% | +260.21% | 6.25B | |
| +3.04% | +0.99% | +38.60% | +87.67% | 49.1B | |
| +1.80% | -0.76% | +84.08% | +63.24% | 47.65B | |
| -1.40% | -6.70% | -4.71% | -9.64% | 23.8B | |
| +2.63% | -24.88% | +55.24% | +455.01% | 21.97B | |
| +1.22% | +0.06% | +43.12% | -26.94% | 17.26B | |
| +1.07% | -2.84% | +25.68% | -42.17% | 15.88B | |
| -2.01% | -3.31% | +55.66% | +195.39% | 15.77B | |
| +3.84% | +10.01% | -26.05% | +870.39% | 14.03B | |
| +0.45% | -4.30% | +39.94% | - | 13.32B | |
| Average | +1.30% | -2.17% | +32.51% | +205.91% | 22.5B | |
| Weighted average by Cap. | +1.53% | -2.58% | +41.26% | +155.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.83B 1.01B 853M 781M 737M 1.37B 95.8B 1.39B 9.27B 3.62B 45.63B 3.77B 3.69B 158B | 7.86B 1.16B 982M 899M 848M 1.58B 110B 1.59B 10.66B 4.16B 52.48B 4.34B 4.25B 182B |
| Net income | 2.65B 390M 331M 303M 286M 533M 37.14B 537M 3.59B 1.4B 17.69B 1.46B 1.43B 61.2B | 2.92B 430M 365M 334M 315M 588M 41B 593M 3.97B 1.55B 19.53B 1.61B 1.58B 67.57B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-10 | 96.50 ¥ | +2.16% | 7,057,202 |
| 26-05-08 | 94.46 ¥ | -1.93% | 4,204,831 |
| 26-05-07 | 96.32 ¥ | +0.83% | 4,984,491 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688578 Stock
Select your edition
All financial news and data tailored to specific country editions
